oxotremorine has been researched along with Allodynia in 3 studies
Oxotremorine: A non-hydrolyzed muscarinic agonist used as a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daigle, TL | 1 |
| Caron, MG | 1 |
| Ben-Sreti, MM | 1 |
| Sewell, RD | 1 |
| Abelson, KS | 1 |
| Höglund, AU | 1 |
3 other studies available for oxotremorine and Allodynia
| Article | Year |
|---|---|
Elimination of GRK2 from cholinergic neurons reduces behavioral sensitivity to muscarinic receptor activation.
Topics: Analysis of Variance; Animals; Body Temperature; Brain; Choline O-Acetyltransferase; Cholinergic Neu | 2012 |
Centrally-mediated hyperalgesia in mice produced by the antimuscarinic agents atropine and hyoscine.
Topics: Animals; Atropine; Humans; Hyperalgesia; Hyperesthesia; Mice; Nociceptors; Oxotremorine; Receptors, | 1981 |
Intravenously administered oxotremorine and atropine, in doses known to affect pain threshold, affect the intraspinal release of acetylcholine in rats.
Topics: Acetylcholine; Animals; Atropine; Dose-Response Relationship, Drug; Hyperalgesia; Injections, Intrav | 2002 |